Update: Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Description:
  Although preventing blood exposures is the primary means of preventing occupationally acquired human immunodeficiency virus (HIV) infection, appropriate postexposure management is an important element of workplace safety. Information suggesting that zidovudine (ZDV) postexposure prophylaxis (PEP) may reduce the risk for HIV transmission after occupational exposure to HIV-infected blood prompted a Public Health Service (PHS) interagency working group, with expert consultation, to update a previous PHS statement on management of occupational exposure to HIV with the following findings and recommendations on PEP.
• Subjects:
  Antiviral Agents Blood-Borne Pathogens Chemoprevention HIV HIV Infections Humans Occupational Exposure Zidovudine
• Source:
  MMWR. Morbidity and mortality weekly report. 1996; 45(22):468-80.
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  8622618
• Document Type:
  Journal Article
• Name as Subject:
  United States. Public Health Service. ; United States. Public Health Service.
• Place as Subject:
  United States
• Pages in Document:
  13 pdf pages
• Volume:
  45
• Issue:
  22
• Collection(s):
  Guidelines and Recommendations Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:4f218a5c9c09bdbabd8f45c3529fe934bf97265887ec4c11c7cb0f64df71f884f4967570fae58375ee5089e84d55bdf79d4e5b4cc8efff5f5a5f273ff39a3e39
• Download URL:
  https://stacks.cdc.gov/view/cdc/7371/cdc_7371_DS1.pdf
• File Type:
  [PDF - 284.04 KB ]